StockNews.com Initiates Coverage on Calithera Biosciences (NASDAQ:CALA)

StockNews.com began coverage on shares of Calithera Biosciences (NASDAQ:CALA) in a report released on Tuesday morning. The brokerage issued a hold rating on the biotechnology company’s stock.

Calithera Biosciences Price Performance

Shares of Calithera Biosciences stock opened at $0.02 on Tuesday. Calithera Biosciences has a 1 year low of $0.01 and a 1 year high of $0.50. The company’s fifty day moving average is $0.02 and its two-hundred day moving average is $0.03.

About Calithera Biosciences

Calithera Biosciences, Inc operates under a plan of liquidation that was approved in January 2023. Previously, the company was engaged in the clinical stage precision oncology biopharmaceutical business. Calithera Biosciences, Inc was incorporated in 2010 and is headquartered in South San Francisco, California.